Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:carboximidic acid
go back to main search page
Accession:CHEBI:48378 term browser browse the term
Synonyms:related_synonym: carboximidic acids



show annotations for term's descendants           Sort by:
 
N-hydroxyacetimidic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Mmp12 matrix metallopeptidase 12 multiple interactions ISO acetohydroxamic acid binds to and results in decreased activity of MMP12 protein CTD PMID:17269766 NCBI chr 8:4,581,785...4,591,687
Ensembl chr 8:4,581,785...4,599,611
JBrowse link
Rilmenidine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Adra2a adrenoceptor alpha 2A affects binding ISO rilmenidine binds to ADRA2A protein CTD PMID:10217548 NCBI chr 1:253,061,480...253,064,280
Ensembl chr 1:253,060,218...253,064,365
JBrowse link
G Taar1 trace-amine-associated receptor 1 increases activity
multiple interactions
ISO rilmenidine results in increased activity of TAAR1 protein
[rilmenidine results in increased activity of TAAR1 protein] which results in increased abundance of Cyclic AMP
CTD PMID:19725810 NCBI chr 1:21,517,742...21,518,740
Ensembl chr 1:21,517,258...21,532,084
JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19800
    chemical entity 19800
      molecular entity 19799
        polyatomic entity 19721
          heteroatomic molecular entity 19662
            oxoacid derivative 14303
              imidic acid 3
                carboximidic acid 3
                  (1Z)-N-\{(5S)-6-hydroxy-5-[(E)-(1-hydroxybutylidene)amino]hexyl\}butanimidic acid 0
                  (1Z)-N-\{(5S)-6-hydroxy-5-[(E)-(1-hydroxydecylidene)amino]hexyl\}decanimidic acid 0
                  (1Z)-N-\{(5S)-6-hydroxy-5-[(E)-(1-hydroxyhexylidene)amino]hexyl\}hexanimidic acid 0
                  (1Z,3R)-N-[(5S)-6-(acetyloxy)-5-\{(E)-[(3R)-1-hydroxy-3-isocyanobutylidene]amino\}hexyl]-3-isocyanobutanimidic acid 0
                  (1Z,3R)-N-[(5S)-6-hydroxy-5-\{(E)-[(3R)-1-hydroxy-3-isocyanobutylidene]amino\}hexyl]-3-isocyanobutanimidic acid 0
                  (2S)-6-Amino-2-[(E)-(hydroxymethylene)amino]hexanimidic acid 0
                  (E,Z)-N~2~,N~6~-bis[(3R)-1-hydroxy-3-isocyanodecylidene]-L-lysine 0
                  (E,Z)-N~2~,N~6~-bis[(3R)-1-hydroxy-3-isocyanododecylidene]-L-lysine 0
                  Neoherculin 0
                  acetimidic acid + 1
                  carbohydroximic acid + 1
                  formimidic acid + 0
                  isourea + 2
Path 2
Term Annotations click to browse term
  CHEBI ontology 19800
    subatomic particle 19799
      composite particle 19799
        hadron 19799
          baryon 19799
            nucleon 19799
              atomic nucleus 19799
                atom 19799
                  main group element atom 19698
                    p-block element atom 19698
                      chalcogen 19450
                        oxygen atom 19423
                          oxygen molecular entity 19423
                            hydroxides 19158
                              oxoacid 18472
                                oxoacid derivative 14303
                                  imidic acid 3
                                    carboximidic acid 3
                                      (1Z)-N-\{(5S)-6-hydroxy-5-[(E)-(1-hydroxybutylidene)amino]hexyl\}butanimidic acid 0
                                      (1Z)-N-\{(5S)-6-hydroxy-5-[(E)-(1-hydroxydecylidene)amino]hexyl\}decanimidic acid 0
                                      (1Z)-N-\{(5S)-6-hydroxy-5-[(E)-(1-hydroxyhexylidene)amino]hexyl\}hexanimidic acid 0
                                      (1Z,3R)-N-[(5S)-6-(acetyloxy)-5-\{(E)-[(3R)-1-hydroxy-3-isocyanobutylidene]amino\}hexyl]-3-isocyanobutanimidic acid 0
                                      (1Z,3R)-N-[(5S)-6-hydroxy-5-\{(E)-[(3R)-1-hydroxy-3-isocyanobutylidene]amino\}hexyl]-3-isocyanobutanimidic acid 0
                                      (2S)-6-Amino-2-[(E)-(hydroxymethylene)amino]hexanimidic acid 0
                                      (E,Z)-N~2~,N~6~-bis[(3R)-1-hydroxy-3-isocyanodecylidene]-L-lysine 0
                                      (E,Z)-N~2~,N~6~-bis[(3R)-1-hydroxy-3-isocyanododecylidene]-L-lysine 0
                                      Neoherculin 0
                                      acetimidic acid + 1
                                      carbohydroximic acid + 1
                                      formimidic acid + 0
                                      isourea + 2
paths to the root